Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 24Lung Neoplasms 14Carcinoma, Medullary 14Neoplasm Metastasis 12Neoplasms 10Thyroid Neoplasms 8Breast Neoplasms 8Glioma 6Prostatic Neoplasms 5Glioblastoma 5Squamous Cell Carcinoma of Head and Neck 4Gliosarcoma 4Colorectal Neoplasms 4Brain Neoplasms 4Pancreatic Neoplasms 3Ovarian Neoplasms 3Head and Neck Neoplasms 3Carcinoma, Renal Cell 3Adenocarcinoma 3Urinary Bladder Neoplasms 2Thyroid Cancer, Papillary 2Stomach Neoplasms 2Recurrence 2Rectal Neoplasms 2Pleural Effusion 2Kidney Neoplasms 2Familial medullary thyroid carcinoma 2Fallopian Tube Neoplasms 2Esophageal Neoplasms 2Disease Progression 2

Interventions

Biopsy 12Peripheral Blood Stem Cell Transplantation 9Cyclophosphamide 9fludarabine phosphate 8Whole-Body Irradiation 8Polymerase Chain Reaction 7Tacrolimus 6Mycophenolic Acid 6Gene Expression Profiling 6Colposcopy 6Busulfan 6Microarray Analysis 5Immunohistochemistry 5Epoetin Alfa 5Celecoxib 5Aminolevulinic Acid 5Sulindac 4Selenium 4Methotrexate 4Melphalan 4Cyclosporine 4Cetuximab 4Antilymphocyte Serum 4Vaginal Smears 3Imiquimod 3Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3Etoposide 3Eflornithine 3Darbepoetin alfa 3Comparative Genomic Hybridization 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precancerous Conditions × vandetanib × Clear all
NCT01414426 2021-01-14

Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck Lesions

University of Chicago

Phase 2 Completed
20 enrolled 7 charts
Head & NeckOther neoplasm

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡